Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × High-Throughput Nucleotide Sequencing × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Colorectal Neoplasms 3 Sarcoma 2 Recurrence 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Stage IIIb and IV Non Small Cell Lung Cancer 1 Solid Tumor, Adult 1 Rare Diseases 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplastic Syndromes, Hereditary 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mouth Neoplasms 1 Microsatellite Instability 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Head and Neck Neoplasms 1 Genetic Predisposition to Disease 1 Colonic Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Medullary 1 COVID-19 1 Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 87 Etoposide 49 Carboplatin 42 Vincristine 40 Isotretinoin 40 Temozolomide 39 Topotecan 38 Melphalan 38 Irinotecan 38 Filgrastim 38 Doxorubicin 36 3-Iodobenzylguanidine 32 Cisplatin 28 Granulocyte Colony-Stimulating Factor 27 sargramostim 26 Peripheral Blood Stem Cell Transplantation 26 dinutuximab 25 Radiotherapy 24 Granulocyte-Macrophage Colony-Stimulating Factor 24 Busulfan 20 Magnetic Resonance Spectroscopy 17 fludarabine 16 aldesleukin 16 Interleukin-2 15 naxitamab 14 humanized 3F8 anti-GD2 monoclonal antibody 14 Thiotepa 13 fludarabine phosphate 12 etoposide phosphate 12 Biopsy 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡